The World Health Organization (WHO) has indicated that Ghana is off track in its efforts to eliminate viral hepatitis by 2030. Key health officials stress the need for increased vaccination, improved access to treatment, and proactive public health measures to prevent the spread of hepatitis B. Current shortcomings in policy and funding are significant barriers to progress.
Dr. Kafui Senya, the Technical Lead for Hepatitis at the World Health Organization (WHO) in Ghana, has raised significant concerns regarding the country’s progress in combating viral hepatitis. He stated that Ghana is currently off track to meet the target of eliminating the disease by 2030. Hepatitis B, a liver-infecting viral illness transmitted through blood and bodily fluids, poses a severe health risk and can culminate in serious complications such as liver inflammation and cancer. In a recent interview, Dr. Senya emphasized the urgency of implementing strategic actions if Ghana is to eliminate viral hepatitis within the set timeframe. He outlined that at least 90 percent of individuals living with hepatitis must be tested and informed of their condition, while 65 percent of those diagnosed should receive treatment. Although hepatitis C can be treated and cured, hepatitis B remains largely uncurable; however, antiviral medications can effectively manage the virus and mitigate the risk of liver cancer. A critical aspect of prevention, according to Dr. Senya, is the vaccination of all newborns against hepatitis B, a measure currently lacking a national implementation policy in Ghana. He remarked, “Currently, Ghana is not providing that vaccine. If every baby born receives the vaccine, they are unlikely to get infected with hepatitis B. Over time, we would have no new cases of hepatitis B infection among children.” The absence of pivotal vaccination measures greatly diminishes the likelihood of achieving the elimination goal set for 2030. The importance of early prevention through vaccination was also stressed by Theobald Owusu-Ansah, President of the Hepatitis Foundation of Ghana. He criticized the reactive approach currently adopted in addressing hepatitis, wherein the country waits for people to contract the illness before offering treatment. He advocated for a preemptive vaccination strategy, citing its successful implementation in other nations. Additionally, he highlighted the critical gap in funding for hepatitis initiatives compared to HIV programs, suggesting this financial shortfall hampers progress. Mr. Owusu-Ansah suggested that Ghana should begin by administering birth doses of the hepatitis B vaccine, as well as identifying and connecting individuals already affected by the virus to affordable care and treatment. He called upon government officials to intensify efforts and investments towards eradicating hepatitis B, including advocating for its integration into the National Health Insurance Scheme (NHIS). He expressed concern over the current out-of-pocket treatment costs that deter individuals from seeking necessary medical assistance. In summary, Ghana is facing considerable challenges in the fight against viral hepatitis. Significant gaps in vaccination policies, funding, and strategic healthcare implementation threaten the country’s ability to meet the 2030 elimination targets. Immediate and decisive action is essential to safeguard the health of future generations and reduce the burden of this preventable disease.
Viral hepatitis, particularly hepatitis B, remains a pressing public health concern in Ghana. Hepatitis B is a viral infection that can lead to serious liver complications, including inflammation and cancer. There is a global initiative to eliminate viral hepatitis by 2030, which requires substantial efforts in vaccination, testing, treatment, and public awareness. WHO has emphasized that proactive measures, especially vaccination of newborns, are crucial to prevent the transmission of hepatitis B, yet Ghana lacks the necessary policies and funding to advance these efforts.
The current status of Ghana’s viral hepatitis management highlights substantial deficiencies in vaccination, funding, and strategic healthcare initiatives. As articulated by health experts, immediate actions are critical to achieving the 2030 elimination target. Without the implementation of necessary preventive measures, such as newborn vaccinations and enhanced treatment accessibility, Ghana risks perpetuating the cycle of hepatitis infection and its related health consequences. Stakeholders, including government officials, must act swiftly to bolster efforts towards hepatitis management and prevention.
Original Source: www.ghanaweb.com
